About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: May 2006
More on Generics, the Pipeline and Communications
There has been a lot of news about generics lately. There are approximately 75 brand name drugs scheduled to go off-patent over the course of the next two years. Last week, the highly lucrative statins saw the first generic among … Continue reading
Posted in Pharma Industry Image, Pricing and Value
3 Comments
Issues Planning, Mapping – A Scenario Book and Shutting the Barn Door After the Horse Has Gone
Part of what I try to accomplish in this space is to provide communications advice that might make the business of drug development, approval and marketing a better process. A new development in news from last week puts today’s focus … Continue reading
Posted in Crisis Communications, Pharma Industry Image
Comments Off on Issues Planning, Mapping – A Scenario Book and Shutting the Barn Door After the Horse Has Gone
FDA Heal Thyself – A Prescription for Crisis Communications
Last week there was an interesting exchange of opposing opinion in USA Today between the paper and Dr. Steven Galson of the FDA regarding the agency’s abilities to protect public health. The paper cited the recent GAO report on the … Continue reading
Posted in Crisis Communications, FDA Image
Comments Off on FDA Heal Thyself – A Prescription for Crisis Communications